Location
United States, North America
Cheque size
$250K - $10M
Investment Stage
Pre Seed
Seed
Series A
Focus Areas
AI
Health IT
Digital Health
BioTech
Wellness & Fitness
Pharmaceuticals
Medical Devices
About Investor
David H. Crean is a life sciences investor and entrepreneur with over 30 years of experience in biotechnology, healthcare, and investment banking. He is the Founder and Managing Partner of Cardiff Advisory and Managing Partner of the Neuroimmune Catalyst Fund, focusing on early-stage investments in innovative healthcare and biotech companies. He also brings extensive expertise in M&A, strategic partnerships, and business development.
Similar Investors
AL
Abdul Ly
United States, North America
$1M - $4M
Seed
,Series A
,PS
Paul Straub
United States, North America
$100K - $2M
Pre Seed
,Seed
,SA
Shaun Abrahamson
United States, North America
$250K - $1M
Pre Seed
,Seed
,RF
Riley Florsheim
United States, North America
$100K - $5M
Pre Seed
,Seed
,SB
Steve Brownlie
United States, North America
$250K - $1.4M
Pre Seed
,Seed
,DG
Danielle Graham
Canada, North America
$100K - $300K
Pre Seed
,Seed
,Is this Your Profile?
If you have any updates, please fill out our form.
